Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Augmenter of Liver Regeneration Reduces Ischemia Reperfusion Injury by Less Chemokine Expression, Gr-1 Infiltration and Oxidative Stress

: Weiss, Thomas S.; Lupke, Madeleine; Dayoub, Rania; Geissler, Edward K.; Schlitt, Hans J.; Melter, Michael; Eggenhofer, Elke

Fulltext urn:nbn:de:0011-n-5828830 (2.7 MByte PDF)
MD5 Fingerprint: d3a61a4ebaacc40402bcda4201bc3b8b
(CC) by
Created on: 31.3.2020

Cells 8 (2019), No.11, Art. 1421, 15 pp.
ISSN: 2073-4409
Journal Article, Electronic Publication
Fraunhofer ITEM ()
ischemia reperfusion; liver regeneration; Chemokines; neutrophils; oxidative stress

Hepatic ischemia reperfusion injury (IRI) is a major complication in liver resection and transplantation. Here, we analyzed the impact of recombinant human augmenter of liver regeneration (rALR), an anti-oxidative and anti-apoptotic protein, on the deleterious process induced by ischemia reperfusion (IR). Application of rALR reduced tissue damage (necrosis), levels of lipid peroxidation (oxidative stress) and expression of anti-oxidative genes in a mouse IRI model. Damage associated molecule pattern (DAMP) and inflammatory cytokines such as HMGB1 and TNFα, were not affected by rALR. Furthermore, we evaluated infiltration of inflammatory cells into liver tissue after IRI and found no change in CD3 or γδTCR positive cells, or expression of IL17/IFNγ by γδTCR cells. The quantity of Gr-1 positive cells (neutrophils), and therefore, myeloperoxidase activity, was lower in rALR-treated mice. Moreover, we found under hypoxic conditions attenuated ROS levels after ALR treatment in RAW264.7 cells and in primary mouse hepatocytes. Application of rALR also led to reduced expression of chemo-attractants like CXCL1, CXCL2 and CCl2 in hepatocytes. In addition, ALR expression was increased in IR mouse livers after 3 h and in biopsies from human liver transplants with minimal signs of tissue damage. Therefore, ALR attenuates IRI through reduced neutrophil tissue infiltration mediated by lower expression of key hepatic chemokines and reduction of ROS generation.